NCT02134925 2025-09-10Vaccine Therapy in Treating Patients With Newly Diagnosed Advanced Colon PolypsNational Cancer Institute (NCI)Phase 2 Active not recruiting110 enrolled 12 charts
NCT00614393 2018-08-08Study of Dalotuzumab (MK-0646) in Combination With Cetuximab and Irinotecan in Metastatic Colorectal Cancer (MK-0646-004)Merck Sharp & Dohme LLCPhase 2 Completed558 enrolled 17 charts